Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance

被引:22
|
作者
Sjoberg, Kim A. [1 ]
Rattigan, Stephen [2 ]
Jeppesen, Jacob F. [1 ]
Lundsgaard, Anne-Marie [1 ]
Holst, Jens J. [3 ]
Kiens, Bente [1 ]
机构
[1] Univ Copenhagen, Dept Nutr Exercise & Sports, Fac Sci, Sect Mol Physiol,August Krogh Ctr, DK-2100 Copenhagen, Denmark
[2] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia
[3] Univ Copenhagen, Dept Biomed Sci, DK-2100 Copenhagen, Denmark
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2015年 / 593卷 / 09期
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
FREE FATTY-ACIDS; MUSCLE MICROVASCULATURE; GLYCEMIC CONTROL; HEALTHY-SUBJECTS; RECEPTOR KINASE; IN-VIVO; TYPE-2; GLP-1; SENSITIVITY; SECRETION;
D O I
10.1113/JP270129
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acute infusion of glucagon-like peptide-1 (GLP-1) has potent effects on blood flow distribution through the microcirculation in healthy humans and rats. A high fat diet induces impairments in insulin-mediated microvascular recruitment (MVR) and muscle glucose uptake, and here we examined whether this could be reversed by GLP-1. Using contrast-enhanced ultrasound, microvascular recruitment was assessed by continuous real-time imaging of gas-filled microbubbles in the microcirculation after acute (5 days) and prolonged (8 weeks) high fat diet (HF)-induced insulin resistance in rats. A euglycaemic hyperinsulinaemic clamp (3 mU min(-1) kg(-1)), with or without a co-infusion of GLP-1 (100 pmol l(-1)), was performed in anaesthetized rats. Consumption of HF attenuated the insulin-mediated MVR in both 5 day and 8 week HF interventions which was associated with a 50% reduction in insulin-mediated glucose uptake compared to controls. Acute administration of GLP-1 restored the normal microvascular response by increasing the MVR after both 5 days and 8 weeks of HF intervention (P < 0.05). This effect of GLP-1 was associated with a restoration of both whole body insulin sensitivity and increased insulin-mediated glucose uptake in skeletal muscle by 90% (P < 0.05) after 5 days of HF but not after 8 weeks of HF. The present study demonstrates that GLP-1 increases MVR in rat skeletal muscle and can reverse early stages of high fat diet-induced insulin resistance in vivo.
引用
收藏
页码:2185 / 2198
页数:14
相关论文
共 50 条
  • [21] Differentiation of glucagon and glucagon-like peptide-1 effects on hepatocytes
    Wang, Xiaozhen
    Conway, James
    Beaton, Michelle
    De Los Reyes, Melissa
    Raja, Rajiv
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E552 - E552
  • [22] Comparison of Short- and Long-Acting Glucagon-Like Peptide-1 Receptor Agonist Effects on Postprandial Glucose and Lipid Excursion via Gastric Emptying
    Kuwata, Hitoshi
    Yabe, Daisuke
    Hamamoto, Yoshiyuki
    Kurose, Takeshi
    Seino, Yutaka
    DIABETES, 2019, 68
  • [23] Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial
    Tack, Cees J.
    Jacob, Stephan
    Desouza, Cyrus
    Bain, Stephen C.
    Buse, John B.
    Nauck, Michael A.
    Petrie, John R.
    Poulter, Neil R.
    Pratley, Richard E.
    Stegmann, Helen Vanya B. K.
    Bosch-Traberg, Heidrun
    Startseva, Elena
    Zinman, Bernard
    DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2450 - 2458
  • [24] EFFECTS OF GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE ON THE CONCENTRATIONS OF INSULIN AND GLUCOSE IN SHEEP
    MARTIN, PA
    FAULKNER, A
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 1993, 105 (04): : 705 - 709
  • [25] Portal glucagon-like peptide-1 and portal glucose synergize to stimulate insulin secretion
    Ionut, V
    Hucking, K
    Bergman, RN
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S106 - S106
  • [26] Glucagon-like peptide-1 stimulates insulin secretion and glucose effectiveness in mice.
    Pacini, G
    Ahrén, B
    DIABETOLOGIA, 1998, 41 : A184 - A184
  • [27] Glucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice
    Thomaseth, K.
    Pavan, A.
    Pacini, G.
    Ahren, B.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (06): : E1808 - E1814
  • [28] Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans
    Larsson, H
    Holst, JJ
    Ahren, B
    ACTA PHYSIOLOGICA SCANDINAVICA, 1997, 160 (04): : 413 - 422
  • [29] Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
    Courtney, Hamish
    Nayar, Rahul
    Rajeswaran, Chinnadorai
    Jandhyala, Ravi
    DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 79 - 87
  • [30] Long-term insulinotropic activity of glucagon-like peptide-1/polymer conjugate on islet microcapsules
    Kim, S
    Bae, YH
    TISSUE ENGINEERING, 2004, 10 (11-12): : 1607 - 1616